Majercsik 2003.

Methods	1. Randomized 2. Double Blind 3. Parallel groups: ‐Placebo ‐Buspirone 30mg/d 4. Duration: six weeks 5. Analysis: LOCF ANOVA
Participants	1. Diagnosis: GAD (DSM‐IV) 2. N = 52 3. Age (mean, SD): 81.05 (1.01) Sex: 100% male Setting: not states History: excluded those who had received any anxiolytic medication in the 6‐month period leading up to the study and was not sufficiently debilitated to warrant exclusion from the study
Interventions	1. Placebo (N = 19 patients) 2. Buspirone (N = 33)
Outcomes	1. HAM‐A
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Unclear risk	B ‐ Unclear